|
Analysis
|
GPI
|
Standard treatment
|
MD
|
95% CI
|
P value
|
I2 (%)
|
|
Age
|
66.6 ± 12.6
|
69.1 ± 12.3
|
− 2.75
|
− 0.64 to 0.83
|
0.13
|
74
|
|
LVEF
|
35 ± 9
|
32 ± 10
|
0.33
|
− 1.83 to 2.49
|
0.63
|
27
|
|
Analysis
|
GPI
|
Standard treatment
|
OR
|
95% CI
|
P value
|
I2 (%)
|
|
Gender (male)*
|
470/640
|
258/397
|
1.43
|
1.09–1.89
|
0.01
|
8
|
|
Diabetes mellitus
|
112/470
|
90/306
|
0.77
|
0.55–1.08
|
0.13
|
0
|
|
Hypertension*
|
247/425
|
168/225
|
0.68
|
0.49–0.94
|
0.02
|
74
|
|
Tobacco use*
|
197/470
|
87/306
|
1.87
|
1.20–2.91
|
0.006
|
36
|
|
Previous MI
|
82/470
|
77/306
|
0.75
|
0.48–1.18
|
0.21
|
25
|
|
3 vessel disease
|
181/425
|
124/225
|
0.64
|
0.29–1.45
|
0.29
|
79
|
|
Left main lesion
|
74/446
|
31/298
|
1.54
|
0.52–4.57
|
0.44
|
76
|
|
Invasive ventilation
|
312/586
|
198/338
|
1.20
|
0.62–2.23
|
0.57
|
65
|
|
IABP
|
363/640
|
149/397
|
2.13
|
0.96–4.72
|
0.06
|
82
|
|
TIMI 0/1 pre-procedure
|
167/595
|
185/346
|
0.60
|
0.19–1.88
|
0.38
|
90
|
- Bernat et al.’s study did not provide information regarding baseline data and was therefore not included in the baseline characteristics analysis
- GPI glicoprotein IIb/IIIa inhibitors, MD mean difference, CI confidence intervals, OR odds ratio, LVEF left ventricular ejection fraction, MI myocardial infarction, IABP intraortic balloon pump, TIMI thrombolysis in myocardial infarction
